You searched for "scarring"
A paperless future – get involved!
Jeremy Hunt’s statement earlier in 2014, about a paperless NHS by 2018, has added momentum to the transition away from paper records. The Tech Review this issue discusses what that will involve and how and why you may want to...Home testing can help glaucoma patients, new study shows
Nearly 60,000 people in Scotland living with glaucoma could benefit from carrying out tests at home, a study funded by Sight Scotland and the Royal College of Surgeons of Edinburgh has shown.Conference Report: Building on a successful 2024: A week of learning at the Kabgayi Eye Unit
2024 was an exceptional year for us at Kabgayi Eye Unit (KEU). We hosted Rwanda’s first-ever international ophthalmology conference, established the Kabgayi Learning and Simulation Centre (KLAS) – a dedicated wet lab and skills transfer centre, and launched our training...Reflections on designing and delivering an undergraduate ophthalmology teaching programme
Dr Alexander Strother reflects on his time designing and delivering a classroom-based programme to ensure that medical students know how to take comprehensive ophthalmic histories from patients. Working as a clinical teaching fellow, in 2021 I had the great privilege...Orbis celebrates International Day of Friendship
International eyecare charity Orbis recognises the importance of strong bonds on International Day of Friendship 2023.
Methotrexate and mycophenolate mofetil for non-infectious uveitis
This is the first reported randomised clinical trial comparing methotrexate versus mycophenolate mofetil (MMF) for the treatment of non-infectious intermediate uveitis, posterior uveitis or panuveitis. To be eligible for recruitment, patients had to be on ≥15mg oral prednisone and demonstrated...
Investigating MOG-IgG as a cause for optic perineuritis
Optic perineuritis can be a manifestation of infectious and systemic inflammatory disorders, but in most cases is considered idiopathic. Diagnosis is established by magnetic resonance imaging (MRI) with the demonstration of optic nerve sheath enhancement with sparing of the optic...
Treatment efficacy of stage 4 ROP
This study aimed to determine the efficacy of combined vitrectomy and anti-VEGF injection for advanced stage 4 ROP with extensive neovascular proliferation (NF). The study included nine infants; six bilateral and three unilateral. Seven were female and the mean gestational...
Management of ocular surface disease
This is a retrospective study of patients with ocular surface disease (OSIDs) treated with IKERVIS in a single centre between 2016 to 2019 with at least six months follow-up. Clinical outcome was defined as successful (resolved or stable disease), active...
Real-world experience of using ciclosporin-A 0.1% in the management of ocular surface inflammatory diseases
This is a retrospective study of patients with ocular surface inflammatory diseases (OSIDs) treated with IKERVIS in a single centre between 2016 to 2019 with at least six months follow-up. Clinical outcome was defined as successful (resolved or stable disease),...
Tocilizumab in Graves’ orbitopathy
This prospective European study looks at the response to tocilizumab in corticosteroid-resistant disease. Tocilizumab (TCZ) is a monoclonal antibody that competitively inhibits IL-6 binding to its receptor. Unlike teprotumumab, the advantage of TCZ is that it is already used within...
